 |
|
|
| |
Simplification to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF from Ritonavir-Boosted Protease Inhibitor
Plus Emtricitabine/Tenofovir DF Maintains HIV Suppression and Improves Fasting Triglycerides at Week 48
|
| |
| |
Reported by Jules Levin
October 6-8, 2014
Infectious Disease Week
October 8-12, 2014
Philadelphia, PA
D Cunningham1, D Shamblaw2, C Zurawski3, W Robbins4, A Scarsella5, T Nguyen6, J Hindman6, R Ebrahimi6, D Piontkowsky6
1Pueblo Family Physicians, Phoenix, AZ, USA; 2La Playa Medical Group and Clinical Research, San Diego, CA, USA; 3Atlanta ID Group, Atlanta, GA, USA;
4Value Health MD, Orlando, FL, USA; 5Pacific Oaks Medical Group, Los Angeles, CA, USA; 6Gilead Sciences, Foster City, CA, USA
|
| |
|
|
|
|
|
